HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke Outcome
- 1 June 2005
- journal article
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (6), 1298-1300
- https://doi.org/10.1161/01.str.0000165920.67784.58
Abstract
Background and Purpose— Statins reduce the risk of stroke recurrence, but the benefits of statins in improving outcome of acute stroke patients have not been well explored.Keywords
This publication has 7 references indexed in Scilit:
- In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-upStroke, 2004
- Favorable Outcome of Ischemic Stroke in Patients Pretreated with StatinsStroke, 2004
- Statins induce angiogenesis, neurogenesis, and synaptogenesis after strokeAnnals of Neurology, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischemic stroke in miceBrain Research, 2002
- The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practiceCurrent Controlled Trials in Cardiovascular Medicine, 2002
- A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in ratsAnnals of Neurology, 2001